{
    "organizations": [],
    "uuid": "b7f9c698d20c9b3aa08cdfd14d7f372d9d90d5ba",
    "author": "",
    "url": "https://www.reuters.com/article/brief-cocrystal-pharma-provides-corporat/brief-cocrystal-pharma-provides-corporate-overview-idUSASC09TAY",
    "ord_in_thread": 0,
    "title": "BRIEF-Cocrystal Pharma Provides Corporate Overview",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 22, 2018 / 11:18 AM / Updated 4 minutes ago BRIEF-Cocrystal Pharma Provides Corporate Overview Reuters Staff March 22 (Reuters) - Cocrystal Pharma Inc: * COCRYSTAL PHARMA REPORTS 2017 FINANCIAL RESULTS AND PROVIDES CORPORATE OVERVIEW AND BUSINESS OUTLOOK * COCRYSTAL PHARMA - ‍AS OF DEC 31, 2017, CO HAD $2.1 MILLION CASH; BASED ON CURRENT PROJECTIONS, CO BELIEVES IT HAS SUFFICIENT FUNDS THROUGH Q2 OF 2018​ Source text for Eikon: Further company coverage:",
    "published": "2018-03-22T13:15:00.000+02:00",
    "crawled": "2018-03-22T13:32:49.015+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "updated",
        "minute",
        "ago",
        "pharma",
        "provides",
        "corporate",
        "overview",
        "reuters",
        "staff",
        "march",
        "reuters",
        "cocrystal",
        "pharma",
        "inc",
        "cocrystal",
        "pharma",
        "report",
        "financial",
        "result",
        "provides",
        "corporate",
        "overview",
        "business",
        "outlook",
        "cocrystal",
        "pharma",
        "dec",
        "co",
        "million",
        "cash",
        "based",
        "current",
        "projection",
        "co",
        "belief",
        "sufficient",
        "fund",
        "q2",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}